Biosense Technologies, founded in 2008, is recognized as a prominent player in Point of Care Testing and Instrumentation within the Indian market. The company operates under the umbrella of Tulip Diagnostics, a subsidiary of Perkin Elmer. This relationship provides a robust foundation for strategic growth and innovation.
Specializing in Biotechnology and Health Care, Biosense leverages cutting-edge technology to address critical health needs across India, increasing access to reliable diagnostic solutions at the point of care.
Headquartered in India, the company attracted its last investment through Debt Financing on February 18, 2019, with financial backing from Sagana Capital. This investment denotes a strategic trust in the company's potential for positive impact and growth in the fast-evolving health care sector.